JPH05502220A - Thialbulin antifungal and antibiotic - Google Patents
Thialbulin antifungal and antibioticInfo
- Publication number
- JPH05502220A JPH05502220A JP3500613A JP50061391A JPH05502220A JP H05502220 A JPH05502220 A JP H05502220A JP 3500613 A JP3500613 A JP 3500613A JP 50061391 A JP50061391 A JP 50061391A JP H05502220 A JPH05502220 A JP H05502220A
- Authority
- JP
- Japan
- Prior art keywords
- composition
- formula
- thialubulin
- tables
- substance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 230000000843 anti-fungal effect Effects 0.000 title claims description 14
- 229940121375 antifungal agent Drugs 0.000 title claims description 13
- 230000003115 biocidal effect Effects 0.000 title description 5
- 239000000126 substance Substances 0.000 claims description 33
- 239000000203 mixture Substances 0.000 claims description 23
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 18
- 229940095731 candida albicans Drugs 0.000 claims description 18
- 241000222122 Candida albicans Species 0.000 claims description 17
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 15
- 239000000284 extract Substances 0.000 claims description 12
- 241000196324 Embryophyta Species 0.000 claims description 11
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 11
- 239000012141 concentrate Substances 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical group O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 239000003429 antifungal agent Substances 0.000 claims description 9
- 241000191967 Staphylococcus aureus Species 0.000 claims description 7
- 239000000463 material Substances 0.000 claims description 7
- 241000894006 Bacteria Species 0.000 claims description 6
- 241000588724 Escherichia coli Species 0.000 claims description 6
- 230000000844 anti-bacterial effect Effects 0.000 claims description 5
- 239000000460 chlorine Substances 0.000 claims description 5
- 238000004128 high performance liquid chromatography Methods 0.000 claims description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 4
- 239000012153 distilled water Substances 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 3
- 239000012871 anti-fungal composition Substances 0.000 claims description 3
- 229910052801 chlorine Inorganic materials 0.000 claims description 3
- 230000002550 fecal effect Effects 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 238000000194 supercritical-fluid extraction Methods 0.000 claims description 3
- 238000004809 thin layer chromatography Methods 0.000 claims description 3
- 201000007336 Cryptococcosis Diseases 0.000 claims description 2
- 241000221204 Cryptococcus neoformans Species 0.000 claims description 2
- 241000194032 Enterococcus faecalis Species 0.000 claims description 2
- 241000194017 Streptococcus Species 0.000 claims description 2
- 229910021529 ammonia Inorganic materials 0.000 claims description 2
- 239000001569 carbon dioxide Substances 0.000 claims description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 2
- 238000004817 gas chromatography Methods 0.000 claims description 2
- 238000002523 gelfiltration Methods 0.000 claims description 2
- 238000004810 partition chromatography Methods 0.000 claims description 2
- 238000004808 supercritical fluid chromatography Methods 0.000 claims description 2
- UNABNUQQYPYJEQ-UHFFFAOYSA-N 2-[4-(6-prop-1-ynyldithiin-3-yl)buta-1,3-diynyl]oxirane Chemical compound S1SC(C#CC)=CC=C1C#CC#CC1OC1 UNABNUQQYPYJEQ-UHFFFAOYSA-N 0.000 claims 2
- 241000588915 Klebsiella aerogenes Species 0.000 claims 2
- 229940092559 enterobacter aerogenes Drugs 0.000 claims 2
- 125000000896 monocarboxylic acid group Chemical group 0.000 claims 2
- LGIIPOBYQDVGNC-UHFFFAOYSA-N 1-chloro-6-(6-prop-1-ynyldithiin-3-yl)hexa-3,5-diyn-2-ol Chemical compound CC#CC1=CC=C(C#CC#CC(O)CCl)SS1 LGIIPOBYQDVGNC-UHFFFAOYSA-N 0.000 claims 1
- DVNOOUAYLUAOAH-UHFFFAOYSA-N 2-chloro-6-(6-prop-1-ynyldithiin-3-yl)hexa-3,5-diyn-1-ol Chemical compound CC#CC1=CC=C(C#CC#CC(Cl)CO)SS1 DVNOOUAYLUAOAH-UHFFFAOYSA-N 0.000 claims 1
- XSKTUQQPJKSVTR-UHFFFAOYSA-N 3-(6-hex-5-en-1,3-diynyldithiin-3-yl)prop-2-yn-1-ol Chemical compound OCC#CC1=CC=C(C#CC#CC=C)SS1 XSKTUQQPJKSVTR-UHFFFAOYSA-N 0.000 claims 1
- 241001423296 Ambrosia chamissonis Species 0.000 claims 1
- 201000002909 Aspergillosis Diseases 0.000 claims 1
- 241001225321 Aspergillus fumigatus Species 0.000 claims 1
- 208000036641 Aspergillus infections Diseases 0.000 claims 1
- 241000187488 Mycobacterium sp. Species 0.000 claims 1
- 241000191940 Staphylococcus Species 0.000 claims 1
- 241000534944 Thia Species 0.000 claims 1
- ZQSBNRZGWNQTIF-UHFFFAOYSA-N Thiarubrine E Natural products CC#CC1=CC=C(C#CC#CC(O)CO)SS1 ZQSBNRZGWNQTIF-UHFFFAOYSA-N 0.000 claims 1
- 241000607479 Yersinia pestis Species 0.000 claims 1
- 229940091771 aspergillus fumigatus Drugs 0.000 claims 1
- 235000009487 beach bur Nutrition 0.000 claims 1
- CBOIHMRHGLHBPB-UHFFFAOYSA-N hydroxymethyl Chemical group O[CH2] CBOIHMRHGLHBPB-UHFFFAOYSA-N 0.000 claims 1
- 238000000926 separation method Methods 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 description 17
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 14
- 239000003960 organic solvent Substances 0.000 description 11
- 229920001197 polyacetylene Polymers 0.000 description 9
- 229930192474 thiophene Natural products 0.000 description 8
- 230000012010 growth Effects 0.000 description 7
- 241000700605 Viruses Species 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 5
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 5
- 206010028980 Neoplasm Diseases 0.000 description 5
- CHXZRHMQQRUVHF-UHFFFAOYSA-N 2-hex-5-en-1,3-diynyl-5-prop-1-ynylthiophene Chemical compound CC#CC1=CC=C(C#CC#CC=C)S1 CHXZRHMQQRUVHF-UHFFFAOYSA-N 0.000 description 4
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 4
- 230000004071 biological effect Effects 0.000 description 4
- 239000003937 drug carrier Substances 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 241000228212 Aspergillus Species 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 3
- 230000000840 anti-viral effect Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 235000019439 ethyl acetate Nutrition 0.000 description 3
- 230000009036 growth inhibition Effects 0.000 description 3
- 230000002147 killing effect Effects 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 231100000760 phototoxic Toxicity 0.000 description 3
- -1 (3-buten-1-ynyl)6(3-buten-1-ynyl)-1,2-dithiacyclohexane -3,5-diene Chemical compound 0.000 description 2
- WCVOGSZTONGSQY-UHFFFAOYSA-N 2,4,6-trichloroanisole Chemical compound COC1=C(Cl)C=C(Cl)C=C1Cl WCVOGSZTONGSQY-UHFFFAOYSA-N 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- 241000589158 Agrobacterium Species 0.000 description 2
- 244000237956 Amaranthus retroflexus Species 0.000 description 2
- 235000013479 Amaranthus retroflexus Nutrition 0.000 description 2
- 241000186781 Listeria Species 0.000 description 2
- 206010027906 Monocytosis Diseases 0.000 description 2
- 241000701029 Murid betaherpesvirus 1 Species 0.000 description 2
- 241000186359 Mycobacterium Species 0.000 description 2
- 244000292604 Salvia columbariae Species 0.000 description 2
- 235000012377 Salvia columbariae var. columbariae Nutrition 0.000 description 2
- 235000001498 Salvia hispanica Nutrition 0.000 description 2
- 238000002814 agar dilution Methods 0.000 description 2
- 210000004102 animal cell Anatomy 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 101150027376 chiA gene Proteins 0.000 description 2
- 235000014167 chia Nutrition 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 239000008121 dextrose Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 201000006512 mast cell neoplasm Diseases 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000003607 modifier Substances 0.000 description 2
- 238000005325 percolation Methods 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- UEZOFWAZJUOMCN-UHFFFAOYSA-N 2beta-hydroxy-2-methylbutanoyl-3alpha-lupulin Natural products CCC(C)C(=O)OC1C(O)CC2C(C)(C3OC4OC(OC)CC4C3)C(C)CC(OC(C)=O)C2(COC(C)=O)C11CO1 UEZOFWAZJUOMCN-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 1
- 235000004135 Amaranthus viridis Nutrition 0.000 description 1
- APKFDSVGJQXUKY-KKGHZKTASA-N Amphotericin-B Natural products O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-KKGHZKTASA-N 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 244000209117 Castanea crenata Species 0.000 description 1
- 235000003801 Castanea crenata Nutrition 0.000 description 1
- 235000014224 Ceanothus americanus Nutrition 0.000 description 1
- 235000001904 Ceanothus herbaceus Nutrition 0.000 description 1
- 235000009344 Chenopodium album Nutrition 0.000 description 1
- 235000000509 Chenopodium ambrosioides Nutrition 0.000 description 1
- 235000005484 Chenopodium berlandieri Nutrition 0.000 description 1
- 244000098897 Chenopodium botrys Species 0.000 description 1
- 235000005490 Chenopodium botrys Nutrition 0.000 description 1
- 235000009332 Chenopodium rubrum Nutrition 0.000 description 1
- 241001337994 Cryptococcus <scale insect> Species 0.000 description 1
- 241000194033 Enterococcus Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241001472926 Heliantheae Species 0.000 description 1
- 241000588748 Klebsiella Species 0.000 description 1
- 208000028018 Lymphocytic leukaemia Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000287462 Phalacrocorax carbo Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 206010034972 Photosensitivity reaction Diseases 0.000 description 1
- 235000014676 Phragmites communis Nutrition 0.000 description 1
- 241000555745 Sciuridae Species 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 241000710960 Sindbis virus Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 229930187185 Thiarubrin Natural products 0.000 description 1
- NSNKOTXFJDNDDD-UHFFFAOYSA-N [4-(5-buta-1,3-diynylthiophen-2-yl)-2-chlorobut-3-ynyl] acetate Chemical compound CC(=O)OCC(Cl)C#CC1=CC=C(C#CC#C)S1 NSNKOTXFJDNDDD-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 1
- 229960003942 amphotericin b Drugs 0.000 description 1
- 230000001032 anti-candidal effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 210000003855 cell nucleus Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 210000003555 cloaca Anatomy 0.000 description 1
- 239000000039 congener Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- IJKVHSBPTUYDLN-UHFFFAOYSA-N dihydroxy(oxo)silane Chemical compound O[Si](O)=O IJKVHSBPTUYDLN-UHFFFAOYSA-N 0.000 description 1
- 230000002900 effect on cell Effects 0.000 description 1
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000001723 extracellular space Anatomy 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 210000003630 histaminocyte Anatomy 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- UEZOFWAZJUOMCN-HKDNVZQMSA-N lupulin A Chemical compound C([C@]12[C@]3(COC(C)=O)[C@@H](OC(C)=O)C[C@@H](C)[C@](C)([C@H]4OC5O[C@@H](OC)CC5C4)[C@H]3C[C@@H](O)[C@@H]1OC(=O)C(C)CC)O2 UEZOFWAZJUOMCN-HKDNVZQMSA-N 0.000 description 1
- 208000003747 lymphoid leukemia Diseases 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 238000001782 photodegradation Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000009291 secondary effect Effects 0.000 description 1
- 238000011218 seed culture Methods 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 150000003577 thiophenes Chemical class 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 241001515965 unidentified phage Species 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 230000029812 viral genome replication Effects 0.000 description 1
- 244000235231 white angels trumpet Species 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
- C07D339/08—Six-membered rings
Abstract
(57)【要約】本公報は電子出願前の出願データであるため要約のデータは記録されません。 (57) [Summary] This bulletin contains application data before electronic filing, so abstract data is not recorded.
Description
【発明の詳細な説明】 チアルブリン抗真菌および抗生剤 関連出願の文献 本出願は、1989年12月7日に出願された特許出願第07/447.893 号の一部継続出願であり、参照によりここに引用する。[Detailed description of the invention] Thialbulin antifungal and antibiotic Related application documents This application is filed under Patent Application No. 07/447.893 filed on December 7, 1989. No. 1, Continuation-in-Part, and is incorporated herein by reference.
発明の分野 本発明は、抗真菌および抗生剤として有用な、チアルブリン(Thiarubr ine)物質および緊密に関連する誘導体の新規な群に関する。さらに本発明は 、チアルブリン物質の新規な単離方法に関“カエナクチス・ドウブラシ(Cha enactis douglasii)およびエリフィラム・ラナタム(Eri phyllum lanatum)からのジチアシクロへキサジエンポリアセチ レン” (Norton、R,A、 ; Finlayson、 Aj、 ; Towers、 G、H,N、 ; PhytochemistrY、 24( 2)、 356−7 (1985))と題する公開物は、カエナクチス・ドウブ ラシの根および、エリフィラム・ラナタムの植物根並びに種培養物から単離した 2つのジチアポリアセチレンを開示している。2つのジチアポリアセチレンはそ れぞれ、化学名3−(l−プロピニル)6(5−ヘキセン−3−イン−1−イニ ル)−1,2−ジチアシクロヘキサ−3,5−ジエンおよび3(ベント−3−イ ン−1−イニル)6(3−ブテン−1−イニル)−1,2−ジチアシクロヘキサ −3,5−ジエンである。これらの化合物には、通称名チアルブリンAとチアル ブリンBが、それぞれ付けられている。field of invention The present invention relates to Thiarubrin, which is useful as an antifungal and antibiotic agent. ine) relates to a novel group of substances and closely related derivatives. Furthermore, the present invention , regarding a new method for isolating thialubulin substances. enactis douglasii) and Eriphyllum lanatum (Eri dithiacyclohexadiene polyacetate from phyllum lanatum) Len” (Norton, R, A, ; Finlayson, Aj, ; Towers, G, H, N, ; PhytochemistrY, 24 ( 2), 356-7 (1985)) is a publication entitled Caenactis doube. Isolated from the roots of Rashi and from the plant roots and seed cultures of Eryphyllum lanatum Two dithiapolyacetylenes are disclosed. The two dithia polyacetylenes are Chemical name: 3-(l-propynyl)6(5-hexen-3-yn-1-yny) )-1,2-dithiacyclohex-3,5-diene and 3(bent-3-yl)-1,2-dithiacyclohex-3,5-diene (3-buten-1-ynyl)6(3-buten-1-ynyl)-1,2-dithiacyclohexane -3,5-diene. These compounds have the common names thialbulin A and thial Bling B is attached to each.
“カエナクチス・ドウブラシのクラウンゴール腫瘍系による抗生チアルブリンの 製造”(Cosio、 E、G、 ; Norton、 R,A、 : Tow ers。“Antibiotic thialubulin due to the crown gall tumor system of Caenactis doubrasi "Manufacturing" (Cosio, E, G, ; Norton, R, A, : Tow ers.
E、; Finlayson、A、J、:Radriguez、E、:Tawe rs、G、H,N、; J、Plant Physol、、 124 (1−2 )、155−64 (1986))と題する、もう1つの公開物はかなり抗菌活 性を示すジチアシクロへキサジエンポリアセチレンを開示している。これらの化 合物を蓄積した培養物は、カエナクチス・ドウブラシのクラウンゴール腫瘍培養 物から赤色領域の選択で得られた。腫瘍は、アグロバクテリウム・ツメフェシエ ンス(Agrobacterium tumefacience)株A277て 誘導された。発見された、主要なアセチレン生成物は、2つのチアルブリン、A とB1およびその相当するチオフェンであった。チアルブリンとチオフェンの平 均収量はそれぞれ、2.5および0.24 mg/g乾燥重量であったが、無傷 植物での値と類似している。生成物は維管束組織の中心部の回りに配置している 細胞間隙に蓄積し、大きさが変わる赤い根瘤を形成する。その構造は、これらの 化合物が蓄積する唯一の器官である、この植物の根の組織機構と天然のままで類 似している。しかしながら、細根の形成は、腫瘍の増殖中のどの段階でも生じな かった。あきらかに、腫瘍系でのこれらのポリアセチレンの蓄積は、細胞トラン スフォーメーションの直接の結果ではなく、現存する組織分化の二次作用である 。E, ;Finlayson, A, J, :Radriguez, E, :Tawe rs, G, H, N,; J, Plant Physol, 124 (1-2 ), 155-64 (1986)) showed significant antibacterial activity. Discloses dithiacyclohexadiene polyacetylenes exhibiting properties. These transformations Cultures that accumulated the compound were crown gall tumor cultures of Caenactis doubrasi. Obtained by selecting the red area from objects. The tumor is Agrobacterium tumefesiae. Agrobacterium tumefaciens strain A277 Induced. The major acetylene products discovered are two thialbulins, A and B1 and its corresponding thiophene. Thialbulin and thiophene The average yields were 2.5 and 0.24 mg/g dry weight, respectively, but no intact Similar to values in plants. Products are arranged around the center of vascular tissue It accumulates in the intercellular spaces and forms red root nodules that vary in size. Its structure is these The plant's root tissue structure, which is the only organ in which compounds accumulate, and its natural analogue. Similar. However, rootlet formation does not occur at any stage during tumor growth. won. Apparently, the accumulation of these polyacetylenes in tumor systems induces cellular transcription. It is not a direct result of transformation, but a secondary effect of existing tissue differentiation. .
公開物“カエナクチス・ドウブラシの毛根培養物でのチアルブリン蓄積” (C onstabel、 C,P、 ; Towers、 G、H,N、; J、 Plant Physiol、、 133(1)、 67−72 (1988) )は、アグロバクテリウム・リゾゲネス(Agrobacterium rhi zogenes)株TR7を使用して確立したC、ドウブラシの毛根培養物を開 示している。1つの培養系が、急速な増殖を維持しながら、非−トランスフオー ム対照根培養物と比較して2倍の量の抗真菌ポリイン、チアルブリンAとBを蓄 積した。Publication “Thialubulin accumulation in hairy root cultures of Caenactis doubrais” (C onstable, C, P,; Towers, G, H, N,; J, Plant Physiol, 133(1), 67-72 (1988) ) is Agrobacterium rhi C. zogenes strain TR7 was used to open hairy root cultures of C. zogenes strain TR7. It shows. One culture system maintains rapid growth while maintaining non-transforming It accumulated twice the amount of the antifungal polyynes, thialbulin A and B, compared to control root cultures. Accumulated.
培地への外因性NAAの添加では、速い増殖と高度のチアルブリン蓄積の組み合 わせを、対照において倍増できなかった。毛根培養物は、対照と比較して、チア ルプリンAに対して少量のチアルブリンBも産生した。Addition of exogenous NAA to the culture medium results in a combination of fast growth and high thialbulin accumulation. The strain could not be doubled in the control. Hairy root cultures showed higher levels of chia compared to controls. A small amount of thialubulin B was also produced relative to lupulin A.
“天然に存在するポリインであるチアルブリンへの抗ウイルス特性” (Hud son J、 B、 ; Graham E、A、 ; Fong R; Fi nlayson A、 J、。“Antiviral properties of thialubulin, a naturally occurring polyyne” (Hud son J, B, ; Graham E, A, ; Fong R; Fi nlayson A, J.
Towers G、)1.N、 ; Planta Med 0(1)、 19 86.5l−54)と題する公開物は、天然に存在するポリインであるチアルプ リンAに関する。Towers G,)1. N, ; Planta Med 0(1), 19 The publication entitled 86.5l-54) describes the naturally occurring polyyne thialp Regarding phosphorus A.
長波UV線(UV−A)の存在下および非存在下での、その抗ウイルス特性を評 価した。4つのウィルスと哺乳類細胞系を標的として使用した。2つの哺乳類ウ ィルス、ネズミサイトメガロウイルスとシンドビスウイルスは、両者とも膜を存 しているが、UV−A線の存在下でのみ化合物に非常に感受性であった。バクテ リオファージT4は、UV−Aでのみ、わずかに影響されたが、バクテリオファ ージM13は完全に影響されなかった。それ故、チアルブリンAは膜を含むウィ ルスに対して光活性である。対照的にマウス細胞は、UV−Aの存在下で中程度 に化合物に感受性で、暗闇でやや感受性が低かった。Evaluate its antiviral properties in the presence and absence of long-wave UV radiation (UV-A). I valued it. Four viruses and mammalian cell lines were used as targets. two mammals cormorant viruses, murine cytomegalovirus and Sindbis virus, both have membranes. However, the compound was highly sensitive only in the presence of UV-A radiation. Bakte Lyophage T4 was only slightly affected by UV-A, but Bacteriophage Age M13 was completely unaffected. Therefore, Thialbulin A is a membrane-containing virus. is photoactive against Rus. In contrast, mouse cells exhibit moderate levels in the presence of UV-A. They were sensitive to compounds in the dark, and slightly less sensitive in the dark.
チアルブリンAは、“天然に存在するジチアシクロへキサジエンポリインである チアルブリンAの抗生特性” (Towers G、H,N、 ;Abramo wski z; Finlayson A、J、 ; Zucooni A; Planta Med O(3)。Thialbulin A is a “naturally occurring dithiacyclohexadiene polyyne. Antibiotic properties of thialubulin A” (Towers G, H, N,; Abramo wski z; Finlayson A, J; Zucooni A; Planta Med O (3).
1985、225−229)にも論じられている。カエナクチス・ドウブラシの 根からのジチアシクロへキサジエンであるチアルブリンAは、アンホテリシンB に匹敵できる濃度で、カンジダ・アルビカンス(Candida albica ns)およびアルベルギルス・フミガッス(Aspergiる。チアルブリンA は、大腸菌(Escherichia coli)、枯草菌(Bacされたチオ フェンは、光毒性で、生物学的作用にはUV−A光を必要とした。チアルブリン A1チオフェンAおよびアルファーターチェニルの、上記の微生物並びにCIO 細胞に対する作用を比較した。1985, 225-229). of Caenactis doubrasi Thialbulin A, a dithiacyclohexadiene from the root, is amphotericin B. Candida albicans (Candida albicans) ns) and Albergillus fumigatus (Aspergi. Thialbulin A) are Escherichia coli, Bacillus subtilis (Bac Phen was phototoxic and required UV-A light for biological effects. Chealburin A1 thiophene A and alpha terchenyl in the above microorganisms and CIO The effects on cells were compared.
ポリアセチレン群およびチオフェンは、“天然に存在するチオフェンとポリアセ チレンの抗ウィルス作用の比較″(Hudson J、B。Polyacetylene group and thiophene are “naturally occurring thiophenes and polyacetylenes”. Comparison of the antiviral effects of tyrene” (Hudson J, B.
; Graham E、 A、 ; Chan G; Finlayson A 、 J、 ; Towers G、)1.N、 ; Pla■ ta Med O(6)、 1986 (Reed、 1987)、 453− 457)に開示されている。; Graham E, A; Chan G; Finlayson A , J,; Towers G,)1. N、 ; Pla■ ta Med O(6), 1986 (Reed, 1987), 453- 457).
種々のチオフェンとポリアセチレン群を含む5つの天然に生じる化合物を、両者 とも膜を有する2つの動物ウィルス、ネズミサイトメガロウイルスとシンドビス ウイルスに対する光毒性活性に関して比較した。アルファーターチェニルは、両 方のウィルスに非常に毒性であったが、長波紫外線の存在下でのみ毒性であった 。Five naturally occurring compounds, including various thiophene and polyacetylene groups, were Two animal viruses with double membranes: murine cytomegalovirus and Sindbis The phototoxic activity against viruses was compared. Alphaterchenil is both was highly toxic to both viruses, but only in the presence of long-wave ultraviolet light. .
効力の順序は、アルファーターチェニルチアルプリンーA〉フェニルヘプタトリ イン> ACBP−チオフェン〉 チオフェン−A(チアルブリンAの加水分解 生成物)であった。ネズミ−CMVは、これらの化合物のいずれによっても不活 性化されたが、依然として培養マウス細胞に有効に浸透し、通常のウィルス複製 部位である細胞核に達することができた。結果を、光毒性チオフェンとポリアセ チレンの可能な作用機構の見地から論じる。The order of potency is alpha terchenylthialpurine-A> phenylheptatri In> ACBP-thiophene> Thiophene-A (hydrolysis of thialbulin A) product). Murine-CMV is inactivated by any of these compounds. sexualized but still effectively penetrate cultured mouse cells and allow normal virus replication. We were able to reach the cell nucleus. The results were compared to phototoxic thiophene and polyacetic acid. Discussed in terms of tyrene's possible mechanism of action.
1984年6月26日に発行されたTowers et al、のカナダ特許第 1゜169.767号は、天然に存在する抱合ポリアセチレンを含む殺セル力リ ア組成物と、それを使用したセルヵリアの駆除法を開示する。Canadian Patent No. Towers et al., issued June 26, 1984. No. 1°169.767 is a cellulicide containing naturally occurring conjugated polyacetylenes. A composition and a method for exterminating cercariae using the same are disclosed.
1984年8月14日に許可された、Towers et al、のカナダ特許 第1、172.460号は、天然に存在する抱合ポリアセチレンを使用する、雑 草の防除法を開示する。Canadian patent of Towers et al., granted August 14, 1984. No. 1,172.460 discloses a miscellaneous method using naturally occurring conjugated polyacetylenes. Disclose grass control methods.
1984年9月4日に許可された、Towers et al、のカナダ特許第 1、173.743号は、天然に存在する抱合ポリアセチレンを使用する、ベス トの防御法を開示している。Canadian Patent No. Towers et al., granted September 4, 1984. No. 1,173.743 discloses a method using naturally occurring conjugated polyacetylenes. Discloses defense methods against
本発明は、式: 1式中、R1はCH,またはCH2R2であり;R,liH; OH; −CH o; C0OHまたハC0oR4テアリ、ココニおいてR,はアルコールから誘 導され; HaはF; C1; Br;または■であり:nは1または2であり;そして mは1または2である: ただしR1がCHlであり、nがlでmが2である場合、R2はCH=CH2で はなく;そしてR1がCLで、nが2でmが1である場合、R2はCH=CH2 ではない1で表される、抗真菌および抗細菌活性を育する新規な物質および薬学 的に許容されるその塩を意図している。The present invention is based on the formula: In formula 1, R1 is CH, or CH2R2; R, liH; OH; -CH o; C0OH or HAC0oR4teari, Coconi, R, is derived from alcohol. guided; Ha is F; C1; Br; or ■: n is 1 or 2; and m is 1 or 2: However, if R1 is CHl, n is l, and m is 2, then R2 is CH=CH2. ; and if R1 is CL, n is 2 and m is 1, then R2 is CH=CH2 Novel substances and pharmaceutics that develop antifungal and antibacterial activity, represented by 1 The intended salts are those that are acceptable to the public.
抗真’mMチyルフUンE (CHj−C−C−R−CC−C)2−cHow− cH2oH>:抗真菌147/lzフlJンF (CH3−c−c−R−(C− C)2−cHcl−cH2oH);抗X菌iチア、+l、+’+JンG (CH 3−c−c−a−<c、cン、、−cuoH−cH2cx>;オヨU抗真菌薬f フルl+J :/H(HOCH2−C″C−R−((C)2−CH=CH2); [式中、Rは である1も意図する。Anti-true’mM CHILF UN E (CHj-C-C-R-CC-C)2-cHow- cH2oH>: Antifungal 147/lzF (CH3-c-c-R-(C- C) 2-cHcl-cH2oH); Anti-X bacteria, +l, +'+JnG (CH 3-c-c-a-<c, c-n, -cuoH-cH2cx>; Oyo U antifungal drug f Full l+J:/H(HOCH2-C″C-R-((C)2-CH=CH2); [In the formula, R is 1 is also intended.
細菌は、約320−400ナノメーターの波長帯の光と共に、あるいは特に、波 長約350ナノメーターの光と共にチアルブリン物質で処置できる。Bacteria are particularly sensitive to light in the wavelength range of approximately 320-400 nanometers. It can be treated with thialubulin material along with light of about 350 nanometers in length.
本発明は、式: [式中、R+はCHjまたはCHJ3であり;R2はH: OH; −CHo: C00I(またはCOOR4であり、ここにおいてR4はアルコールから誘導 され; HaはF; CI Br;またはrであり;nは1または2であり;そして mは1または2である; ただしR1がCHzであり、nが1でmは2である場合、R2はC)l=cH2 ではなく;そしてR1がCH3であり、nか2でmが1である場合、R2はCH =CH2ではない1のチアルブリン物質および薬学的に許容されるその誘導体を 、製剤学的に許容される担体と共に含有してなる抗真菌組成物も意図する。The present invention is based on the formula: [In the formula, R+ is CHj or CHJ3; R2 is H: OH; -CHO: C00I (or COOR4, where R4 is derived from alcohol is; Ha is F; CI Br; or r; n is 1 or 2; and m is 1 or 2; However, if R1 is CHZ, n is 1, and m is 2, then R2 is C)l=cH2 and if R1 is CH3 and n or 2 and m is 1, then R2 is CH 1 thialbulin substance that is not =CH2 and a pharmaceutically acceptable derivative thereof , along with a pharmaceutically acceptable carrier, are also contemplated.
組成物では、Haは塩素、R3は0HSR3は0HSnは1およびmは2であり 得る。担体は、蒸留水、食塩水または他の製剤学的に許容される担体でありうる 。In the composition, Ha is chlorine, R3 is 0HSR3 is 0HSn is 1 and m is 2. obtain. The carrier can be distilled water, saline or other pharmaceutically acceptable carrier. .
組成物は、暗闇で、さらに効果的には約320−400ナノメーターの波長を有 する、または特に、約350ナノメーターの波長を育する光の存在下で、大腸菌 、黄色ブドウ球菌、糞便レンサ球菌(Streptococcus faeca lis ) 、ミコバクテリウム種(Mycobacterium sス、アス ペルギルス・フミガラスまたはクリプトコックス・ネオ)すルマンス(Cryp tococcus neoformans)の防除にも同様に使用できる。The composition can be used in the dark, more preferably having a wavelength of about 320-400 nanometers. or, in particular, in the presence of light growing at a wavelength of about 350 nanometers, E. coli , Staphylococcus aureus, Streptococcus faeca lis), Mycobacterium spp. Pergillus fumigalas or Cryptococcus neo)surumans (Cryp It can also be used to control P. tococcus neoformans).
前述のチアルブリン物質は、組成物中に約1−100ナノグラム/ml担体の濃 度、または特に、約10ナノグラム/ml担体の濃度で存在する。The aforementioned thialubulin material is present in the composition at a concentration of about 1-100 nanograms/ml carrier. or particularly at a concentration of about 10 nanograms/ml carrier.
本発明は、カンジダ・アルビカンスまたはアスペルギルス(Aspergi 1 lus)に感染している宿主を、抗真菌組成物の、式:H: −HCCI−CH zOf(; CHOHCH2ClまたはCH=CH,テある]の化合物にさらす ことから成る、カンジダ・アルビカンスまたはアスペルギルスの防除方法も意図 する。The present invention relates to Candida albicans or Aspergillus (Aspergi 1). A host infected with H. lus) is treated with an antifungal composition of the formula: H: -HCCI-CH Exposure to the compound zOf(; CHOHCH2Cl or CH=CH, Te) A method of controlling Candida albicans or Aspergillus consisting of do.
カンジダ・アルビカンスは、カンジダ・アルビカンスに対して、約1.0=約1 00ナノグラム/ml蒸留水の範囲のチアルブリンの濃度で処置できる。Candida albicans is about 1.0 = about 1 It can be treated with concentrations of thialubulin ranging from 0.00 nanograms/ml distilled water.
本発明は、チアルブリンDおよび製剤学的に許容できる担体から成る抗真菌組成 物に関する。チアルブリンDは、7ナノグラム/ml担体の濃度で組成物中に存 在できる。組成物中の担体は水または他のいずれの製剤学的に許容できる担体で あってもよい。The present invention provides an antifungal composition comprising thialubulin D and a pharmaceutically acceptable carrier. relating to things. Thialbulin D is present in the composition at a concentration of 7 nanograms/ml carrier. I can exist. The carrier in the composition is water or any other pharmaceutically acceptable carrier. There may be.
本発明は、カリフォルニア州南部からカナダのブリティッシュ=コロンビア州ま での範囲の海岸地域にみられる一般的なブタフサ、アンプロシア・カミソニスC Ambrosia charnissonis)アステラセア(Asterac eaeXヘリアンチ(Heliantheae)族)の抽出物から単離した、新 規なジチアシクロへキサジエン化合物群の発見に基づく。根組織の抽出物から単 離した新規な化合物は、著しい抗真菌および抗細菌活性を存することが見いださ れた。The present invention extends from southern California to British Columbia, Canada. A common pigweed, Amprosia camisonis C, found in coastal areas ranging from Ambrosia charnissonis) Asteracea eaeX Heliantheae family). Based on the discovery of a group of novel dithiacyclohexadiene compounds. from root tissue extract. New compounds isolated have been found to possess significant antifungal and antibacterial activity. It was.
カエナクチス・ドウブラシ、A、カミソニア、および他の種を含むアステラセア 科のものから以前に単離されたジチアシクロへキサジエンに構造がいくらか類似 している化合物、すなわちチアルブリンAとBは総称的に造語チアルブリンと称 されてきた。Asteracea, including Caenactis doubrasi, A., Camisonia, and other species somewhat similar in structure to dithiacyclohexadiene previously isolated from the family The compounds that contain these substances, namely thialubulin A and B, are collectively called thialubulin. It has been.
発見された新規なチアルブリン物質および、その緊密に関係している同族体は以 下の一般式: [式中、R+はCH,またはCH,R,であり;R2は: R3はH; OH; −CHo; C0OHまたはCOOR4てあり、ここにお いてR4はアルコールから誘導され; f(aはF; C1; Br; Iであり;nは1または2であり;そして mは1または2である; ただしR+がCH3であり、nが1でmが2である場合は、R2はCH=CH7 ではなく、R1がCH3、nが2でmが1である場合は、R2はCH=CH2で はない]で表される。The newly discovered thialubulin substances and their closely related congeners are listed below. General formula below: [wherein R+ is CH, or CH, R,; R2 is: R3 is H; OH; -CHO; C0OH or COOR4, and here and R4 is derived from alcohol; f (a is F; C1; Br; I; n is 1 or 2; and m is 1 or 2; However, if R+ is CH3, n is 1 and m is 2, then R2 is CH=CH7 Instead, if R1 is CH3, n is 2, and m is 1, then R2 is CH=CH2. It is expressed as "No".
一連の5つの新規な物質が化学的に同定され、総称者チアルブリンと指名され、 以下の文字表示が与えられた:2、チアルブU ンE:CCH3−C=C−R− CC=C)2−CHOH−CH20H):3、チアルブ’J ンF:(CH,− C’C−R−(C=C)2−CHCI−CHzOH);4、チア/I、プリンG :(CHs−C=C−R−(C=C)z−CHOH−CHxCυ;および5、チ ア)Ivブ’) :/ l(: (HOCH2−CEC−R−(CEC) !− CHECH2) ;ここでRは 治療上有効なチアルブリン抗真菌および抗細菌剤は、以下の工程から成る方法で 製造する: (a)全植物、植物の部分またはその組織培養物を含む、例えばアンプロシア・ カミソニス(var、 )のような、チアルブリンを含むアステラセア科の植物 組織を水で洗い、自然乾燥するか、凍結するか、あるいは種々の有機溶媒(すな わちヘキサン、メタノール等)中で保存する; (b) (a)で得られた根および/または種々の植物部分(すなわち根、葉、 茎等)を、直接凍結乾燥するか、または根の皮を剥がしモして/または凍結乾燥 するか、または混合し、あるいは直接使用する; (C) (a)または(1+)で得られた植物部分を、種々の有機溶媒(ヘキサ ン、酢酸エチル、メタノール等)でパーコレーションにより、あるいは種々の溶 媒(ヘキサン、メタノール等)を使用した冷有機溶媒抽出とその後の濾過または 遠心分離により、または超臨界流体抽出法(SFEXすなわち抽出用溶媒として 二酸化炭素またはアンモニアを使用)により抽出する; (d)工程(C)から得られた有機溶媒含有抽出物を真空で濃縮し、移動相とし て水+水混和性有機溶媒を用いてゲル濾過(例えばセファデックスで)にかける ;または、これとは別に(e)工程(C)から得られた有機溶媒含有抽出物を真 空で濃縮し、移動相として緩衝液の存在または不在下に水、および/または水+ 水混和性有機溶媒を使用して、逆相TLC、カラムまたはHPLCクロマトグラ フィーにかける:あるいは、これとは別に、(f)工程(C)から得られた有機 溶媒含有抽出物を真空で濃縮し、移動相として種々の有機溶媒(すなわちフレオ ン、低沸点炭化水素、単独でまたは例えばジエチルエーテル、酢酸エチル等の極 性調節剤と混合して)を用いてシリカゲルTLC,、カラムまたはHPLCクロ マトグラフィーにかける;あるいはこれとは別に(g)工程(C)から得られた 有機溶媒含有抽出物を真空で濃縮し、種々のガスを単独で使用するか、または極 性調節剤(すなわち水、メタノール等)と混合して5FE(超臨界流体抽出法) または5FC(超臨界流体クロマトグラフィー)を実施する;または、これとは 別に (h)工程(C)から得られた有機溶媒含有抽出物を真空で濃縮し、無水二相系 (すなわちヘキサン/アセトニトリル等)を使用して向流分配クロマトグラフィ ーにかける:または、これとは別に(i)工程(C)から得られた有機溶媒含有 抽出物を真空で濃縮し、ガスクロマトグラフィーにかける: (j)チアルブリン含有画分は、赤あるいは赤/茶の発色団バンドを示し、UV または可視(λ=200−550nm)検知器で検出する;(k)工程(d)の 通りに、[JV/可視−活性画分を集め濃縮して、チアルブリンを得る;または 、これとは別に(1)工程(e)の通りに、UV/可視−活性画分を集め濃縮し て、チアルブリンを得る;または、これとは別に(m)工程(f)の通りに、U V/可視−活性画分を集め濃縮して、チアルブリンを得る;または、これとは別 に(n)工程(g)の通りに、UV/可視−活性画分を集め濃縮して、チアルブ リンを得る;または、これとは別に(0)工程(h)の通りに、UV/可視−活 性画分を集め濃縮して、チアルブリンを得る;または、これとは別に(p)工程 (i)の通りに、UV/可視−活性画分を集め濃縮して、チアルブリンを得る 4、3 チアルブリンの適用 本発明の新規なチアルブリン化合物は、暗闇で強い抗真菌活性を示し、320− 400nmの波長帯の、特に350nmの紫外線A光と共に強い抗真菌および殺 菌活性を示す。A series of five new substances have been chemically identified and collectively named thialubrin. The following letter designation was given: 2. CHARBURN E: CCH3-C=C-R- CC=C)2-CHOH-CH20H):3, Chalbu'J F:(CH,- C'C-R-(C=C)2-CHCI-CHzOH); 4, Chia/I, Purine G :(CHs-C=C-R-(C=C)z-CHOH-CHxCυ; and 5, CH a) Iv b’) :/ l(: (HOCH2-CEC-R-(CEC)!- CHECH2); Here, R is Therapeutically effective thialubulin antifungal and antibacterial agents are produced by a method consisting of the following steps: Manufacture: (a) including whole plants, plant parts or tissue cultures thereof, e.g. Plants of the Asteraceae family, including Thialubrin, such as Camisonis (var) Tissues can be washed with water, air-dried, frozen, or treated with various organic solvents (e.g. storage in hexane, methanol, etc.); (b) Roots and/or various plant parts obtained in (a) (i.e. roots, leaves, (e.g. stems), directly freeze-dried or by peeling the roots and/or freeze-drying. or mix or use directly; (C) Plant parts obtained in (a) or (1+) are treated with various organic solvents (hexane percolation, ethyl acetate, methanol, etc.) or by percolation with various solutions. Cold organic solvent extraction using a solvent (hexane, methanol, etc.) followed by filtration or by centrifugation or by supercritical fluid extraction (SFEX, i.e. as an extraction solvent). (using carbon dioxide or ammonia); (d) Concentrate the organic solvent-containing extract obtained from step (C) in vacuo and use it as the mobile phase. gel filtration (e.g. with Sephadex) using water + water-miscible organic solvent ; or alternatively, (e) the organic solvent-containing extract obtained from step (C) is Concentrate empty, water in the presence or absence of buffer as mobile phase, and/or water + Reverse phase TLC, column or HPLC chromatography using water-miscible organic solvents. or, alternatively, (f) the organic material obtained from step (C). The solvent-containing extract was concentrated in vacuo and various organic solvents (i.e. Freo low-boiling hydrocarbons, alone or as polar compounds such as diethyl ether, ethyl acetate, etc. using silica gel TLC, column or HPLC chromatography (mixed with a sex modifier). matographed; or alternatively (g) obtained from step (C) Concentrate organic solvent-containing extracts in vacuo, using various gases alone or with polar 5FE (supercritical fluid extraction) by mixing with a sex modifier (i.e. water, methanol, etc.) or perform 5FC (supercritical fluid chromatography); or what is this? separately (h) Concentrate the organic solvent-containing extract obtained from step (C) in vacuo to form an anhydrous two-phase system. Countercurrent partition chromatography using (i.e. hexane/acetonitrile etc.) - or separately (i) containing the organic solvent obtained from step (C) Concentrate the extract in vacuo and subject to gas chromatography: (j) Thialbulin-containing fractions show red or red/brown chromophore bands and UV or detected with a visible (λ=200-550nm) detector; (k) step (d); [Collect and concentrate the JV/Visible-active fractions to obtain thialubulin; or , separately (1) collect and concentrate the UV/visible-active fraction as per step (e). or alternatively (m) as in step (f) to obtain thialbulin; V/Visible - collect and concentrate the active fractions to obtain thialubulin; or alternatively (n) Collect and concentrate the UV/Visible-active fraction as per step (g). or alternatively (0) UV/visible-activation as in step (h). collecting and concentrating the sexual fractions to obtain thialubulin; or, separately, step (p) Collect and concentrate the UV/Visible-active fractions as in (i) to obtain thialubulin. 4, 3 Application of Thialbulin The novel thialubulin compounds of the present invention exhibit strong antifungal activity in the dark and exhibit 320- Strong antifungal and killing properties with UV-A light in the 400nm wavelength range, especially 350nm. Shows fungal activity.
これらの物質は、暗闇でカンジダ・アルビカンス、アルベルギルス・フミガラス 、クリプトコックス・ネオフォルマンスの株を死滅させるのに有効である。これ らは、大腸菌、黄色ブドウ球菌、糞便レンサ球菌、ミコバクテリウムおよびエン テロバクタ−・アエロゲネスを死滅させるのに有効である。These substances can kill Candida albicans, Albergillus fumigara in the dark. , is effective in killing strains of Cryptococcus neoformans. this et al., Escherichia coli, Staphylococcus aureus, fecal streptococci, Mycobacterium and Enzyme. Effective in killing Terrorobacter aerogenes.
それ故、チアルブリン化合物は、有利には、上記の真菌および細菌により誘発さ れた感染の治療に使用する。例えばチアルブリンDと称するエポキシド化合物は 、新規な複合イオウ含有物質である。チアルブリンDは特定の式コ で表すことができる。Therefore, thialubulin compounds are advantageously used to induce the above fungi and bacteria. used to treat infected infections. For example, an epoxide compound called Thialbulin D is , a new complex sulfur-containing substance. Thialbulin D has a specific formula It can be expressed as
非常に低濃度での極めて高い抗真菌活性は、’hn vivoすなわちヒト患者 に対する有用性を示唆する。Extremely high antifungal activity at very low concentrations has been shown to be effective in vivo, i.e. in human patients. suggests its usefulness for
化学薬品、チアルブリンDは光感受性であり、光線下で相当するチオフェンに分 解する。それ故、この化学薬品を暗闇で保存し、有効であるためには青色光線お よび紫外線の不在下で抗真菌治療を実施する必要がある。The chemical Thialbulin D is photosensitized and splits into the corresponding thiophene under light. Understand. Therefore, this chemical must be stored in the dark and exposed to blue light to be effective. Antifungal treatment should be carried out in the absence of light and UV light.
以下の表にした一連の試験で、チアルブリンD、E、F、GおよびHが非常に低 い濃度で、すなわちナノグラム/mlの範囲で、カンジダ・アルビカンスの増殖 を阻止することを示す。In the series of tests tabulated below, thialubulin D, E, F, G and H were found to be very low. growth of Candida albicans at low concentrations, i.e. in the nanogram/ml range. Indicates that it prevents
以下の実施例は本発明を説明するものであるが、いかなる場合もその制限を意図 するものではない。The following examples are illustrative of the invention but are not intended to limit it in any way. It's not something you do.
アンプロシア・カミソニスは、カルフォルニア州マリン力つンティ(Marin County)から、およびブリティッシュエコロンビア州タイアスワーセン (Tiaswaassen)から採集した。Amprosia Kamisonis is a native of Marin, California. County) and Tyersworthen, British Columbia. (Tiaswaassen).
凍結乾燥根(350−500g)を、冷MeOHで抽出し、30°Cで真空濃縮 し、MeCNに再溶解した。合わせた抽出物をCHCl、に取り、乾燥し蒸発さ せた。残留物をシリカゲル60カラム(Merck70−230メツシユ)でク ロマトグラフィーにかけ、n−へブタン−〇−ヘキサン(1:4)から勾配を付 けてn−ヘキサン−EtOAc(2:3)に変え、最後にEtOAcで溶出した 。抽出物とHPLC分析の画分を乾燥させ、MeCNに再懸濁した。Lyophilized roots (350-500 g) were extracted with cold MeOH and concentrated in vacuo at 30 °C. and redissolved in MeCN. The combined extracts were taken up in CHCl, dried and evaporated. I set it. The residue was filtered on a silica gel 60 column (Merck 70-230 mesh). chromatography with a gradient starting from n-hebutane-〇-hexane (1:4). then changed to n-hexane-EtOAc (2:3) and finally eluted with EtOAc. . The extracts and fractions for HPLC analysis were dried and resuspended in MeCN.
試料(20および100μl)を、流速1.0ml/分でMeCN−HJ(18 ニア)を使用し、MCl−10逆相カラム(4x 300+nm)を用いたパリ アン(Varian)5000液体クロマトグラフに注入した。チアルブリンF とGとHの良好な分割はMeCN−HJ(2:3および1:1)で達成され、各 化合物は回収HPLC画分をCHCl、zで抽出して単離した。全ての処理は、 化合物の光分解を防ぐために薄明かりで実施した。Samples (20 and 100 μl) were transferred to MeCN-HJ (18 Paris using a MCl-10 reverse phase column (4x 300+nm) Injected onto a Varian 5000 liquid chromatograph. Chialburin F A good resolution of G and H was achieved in MeCN-HJ (2:3 and 1:1), and each Compounds were isolated by extracting the collected HPLC fractions with CHCl,z. All processing is It was carried out in dim light to prevent photodegradation of the compounds.
チアルブリンD: uvλMeCN 、、、 nm:484.344.272 ; MS m/z(相対強度):244 (M) +(100) 、 214 、(75)、182 (21)、170 (98)。Thialbulin D: uvλMeCN, nm: 484.344.272 ; MS m/z (relative intensity): 244 (M) + (100), 214 , (75), 182 (21), 170 (98).
チアルブリンE:UVλMeCN 、、、 nm:482.342.326(s h); MS m/Z(相対強度’): 262 (M)+(100) 、23 1 、(M−CH2Of() +(80)、!99(M−CH20H−3) + (15)。Thialbulin E: UVλMeCN, nm: 482.342.326 (s h); MS m/Z (relative intensity'): 262 (M) + (100), 23 1, (M-CH2Of() + (80), !99(M-CH20H-3) + (15).
チアルブリンF: UV−vis λMeCN 、、、 nm:484.344 .230 ;MS m/2(相対強度’): 279.9783 (M) +( 80)、249 [M−CH20H] ’ (30)、248 (M−3)” (50)、217 cM−s−cH,otu +、(48)。Thialbulin F: UV-vis λMeCN, nm: 484.344 .. 230; MS m/2 (relative intensity’): 279.9783 (M) + ( 80), 249 [M-CH20H]’ (30), 248 (M-3)” (50), 217 cM-s-cH, otu +, (48).
チアルブリンQ:IJV−viSλMeCN 、、、 nm:484.342. 22B ;MS m/2(相対強度): 279.9780 (M) ” 、( 100) 、248 (M−S) ” 、 (+8) 244 (M−HCI) ” (50)、231 、[M−CH20H] ” (98)、199 (M− CH2C1−3)” (30)。Thialbulin Q: IJV-viSλMeCN, nm: 484.342. 22B; MS m/2 (relative intensity): 279.9780 (M)”, ( 100), 248 (M-S)”, (+8) 244 (M-HCI) "(50), 231, [M-CH20H]" (98), 199 (M- CH2C1-3)” (30).
チアルブリンH: [JV−visλMeCN 、、、 nm: 490.35 4.232 、MSm/z(相対強度): 244.0009 (M) ” 、 (100)、227(M−OH) ”、(5)、212 (M−3) ” (6 5)、195 (M−3−OH)” (6)。Thialbulin H: [JV-visλMeCN, nm: 490.35 4.232, MSm/z (relative intensity): 244.0009 (M)”, (100), 227 (M-OH)", (5), 212 (M-3)" (6 5), 195 (M-3-OH)” (6).
5.2. チアルブリンの生物学的活性以下の実験は、本発明のチアルブリンの 生物学的活性を説明する。5.2. Biological activity of thialubulin The following experiments were performed on the biological activity of thialubulin of the present invention. Describe biological activity.
(本頁以下余白) 表1 24時間さらしている間に50%成長阻止(μg/ml)を引力ンノダ・アルビ カンス 0.028 0.0006 0.00!4 0.037P815 0. .035 0.12 0.024 > 5.0L1210 0.035 0.0 47 0.027 2.8WEHI−30,0270,050,Oj 1.93 丁3 0.45 0.48 0.12 > 5.0P815 =マウス肥満細胞 腫 L1210 =マウスリンパ球白血病 WEHI−3=マウス骨髄性単球 3T3=マウス線維芽細胞 表2 異なる動物細胞系に対する、チアルブリンと表2は、動物細胞の50%成長阻止 に必要な濃度が、カンジダ・アルビカンスの50%成長阻止に必要な用量より何 倍、高いかを示す。(Margins below this page) Table 1 Attracting 50% growth inhibition (μg/ml) during 24-hour exposure Kansu 0.028 0.0006 0.00!4 0.037P815 0. .. 035 0.12 0.024 > 5.0L1210 0.035 0.0 47 0.027 2.8WEHI-30,0270,050,Oj 1.93 D3 0.45 0.48 0.12 > 5.0P815 = Mouse mast cells Tumor L1210 = Mouse lymphocytic leukemia WEHI-3=mouse myeloid monocytes 3T3=mouse fibroblast Table 2 For different animal cell lines, thialubulin and Table 2 showed 50% growth inhibition of animal cells. What is the concentration required to inhibit Candida albicans growth by 50%? Indicates whether it is times higher or higher.
!l 八 = ; 々 P 18!I18!I 閣 會 シ 印 駆 全 圏 !、2亥ト一二 へ 二 女 FiE 旬 表5 2 糞便レノサ球菌(Streptococcus faecalls) 29 212 10.0003 大腸菌(Escherlchli colt) 25 992 1.0004 緑膿菌(Pseudeionas aeruglnos i) 27853 10.0005 黄色ブドウ球1II(Sf富phyloc occus aureIIs) 29213 10.00061ノテCバクター ・ア10ゲ本X(F、nLerobicLerierogenes)35029 10.0007 肺炎桿菌(Klebslella pne+II+onlae ) 33495 10.0008 表皮ブドウ球菌(Slaphyloc++c cas epldersls) 29972 10.0009 クリ1トプテカ ス°ネf7th7ンス(Cryplococcns neoformxns) F548 6410、jンブダ・&x−F)Oビカリス(CtndldaPse udotroplcills)10.00011 黄色ブドウ球菌 (Staphylococcusaureus(se4mcylllures、 ))’10.00012 緑膿菌(Pseudomonxs aeruglno sa+ 141 > 10.00013 緑膿菌(Pseudosonxs i eruglnosa) 205 > 10.00014 緑膿菌(Pseudo monxs ieruglnosa) 3E5 10.00015ヂノトモtス ・マルトフイリ7(Xanlhosonasmallophllla13B61 0.00016 黄色ブドウ球菌 (SLaphylococcos aureus(melaeylllu re s、)) 84287 10.00017.1’iNバクター(Aclneto bacler)C421,00018,7ノ$1バククー(Aclnetoba eler)6C101,00019エツチσバクター・クロアカz(E+uer obac+ercloaeoe+I^51.00020エノテロバクター・クロ アカニ(En+erobiclerclomcoIり9E51.00021、 7スベルギルス(Asperglllus) 05 3222、カンジダ(Ca ndlda) 01 1623 カンジダ(Candlda) 02 1624 カンジダ(Cindldi) 03 6425 カンジダ(Candldm) R4197+626エンテaバクター5p(Enlerobicjersp、 )9E710.00027 霊菌(Serrmlla marscenes) 3A3 10.00028 単球症リステリア(Llslerlm sonoc ylogenes) 106 10.00029 単球症リステリア(Llsl erla aonocylogenes) 301 10.00030 エッチ off+倉X・7r1食リス(Enterococcus fiecills) IA3 10.00031 クレブシラ種(にIebslellm sp、) 1.00032 カッシダ(Candlda) F617 833、 エンテ ロコテカスげンタマインノ耐性)(Enterococcus(gentasy cln r、en、、)) 1034、 Tスベlflス(Asperglll us) F2O364351ノテロゴ91ス・フrXjリス(Enleroco ecu fiecalls) 207 1.000結果は寒天希釈法で得た。! l 8 = ; P 18! I18! I Cabinet Meeting Shi Seal Drive all areas ! , 2 pigs, 12 To 2nd woman FiE Shun Table 5 2 Streptococcus faecalls 29 212 10.0003 Escherichia coli (Escherlchli colt) 25 992 1.0004 Pseudomonas aeruginosa i) 27853 10.0005 Staphylococcus aureus 1II (Sf phyloc occus aureIIs) 29213 10.00061 note C bacter ・A10 Game Book X (F, nLerobicLerierogenes) 35029 10.0007 Klebsrella pne+II+onlae ) 33495 10.0008 Staphylococcus epidermidis (Slaphyloc++c cas epldersls) 29972 10.0009 Kuri 1 Topteka Sune f7th7th (Cryplococcns neoformxns) F548 6410, j Nbuda & x-F) O Bikaris (CtndldaPse udotropcills) 10.00011 Staphylococcus aureus (Staphylococcusaureus(se4mcyllures, ))’10.00012 Pseudomonas aeruginosa sa+ 141> 10.00013 Pseudomonas aeruginosa eruglnosa) 205 > 10.00014 Pseudomonas aeruginosa monxs ieruglnosa) 3E5 10.00015 ・Maltophylla 7 (Xanlhosonasmallophulla13B61 0.00016 Staphylococcus aureus (SLaphylococcos aureus (melaeyllu re s, )) 84287 10.00017.1’iN Bacter (Aclneto bacler)C421,00018,7ノ$1Baku (Aclnetoba) eler) 6C101,00019 Etsuchi σ Bacter cloaca z (E+uer obac+ercloaeoe+I^51.00020 Enoterobacter clo Akani (En+erobiclercromcoIri9E51.00021, 7 Aspergllus 05 3222, Candida (Ca ndlda) 01 1623 Candida 02 1624 Candida (Cindldi) 03 6425 Candida (Candldm) R4197+626 Entheobacter 5p (Enlerobicjersp, )9E710.00027 Serrmilla marscenes 3A3 10.00028 Monocytosis Listeria (Llslerlm sonoc ylogenes) 106 10.00029 Monocytosis Listeria (Llsl erla aonocylogenes) 301 10.00030 Etch off+kura IA3 10.00031 Klebsiella species (Iebslellm sp,) 1.00032 Candlda F617 833, Ente Enterococcus (gentasy) cln r, en,, )) 1034, T smooth (Aspergllll) us) F2O364351noterogo91s frxj squirrel (Enleroco ecu 207 1.000Results were obtained by the agar dilution method.
種々の用量のThDの入ったミューラ・ヒントン(Mutter HIn+on )寒天プレート(pH−7,4)にlo’cfu/スポットで接種し、34℃で 21時間、インキュベートした。Mutter HIn+on with various doses of ThD ) Agar plates (pH-7,4) were inoculated with lo’cfu/spot and incubated at 34°C. Incubated for 21 hours.
MICは増殖しない最小濃度である。MIC is the minimum concentration at which no growth occurs.
表6 チアルブリンA、D、E、に対する アスペルギルス・フミガラス チアルブリンA 10,000 .27チアルブリンD 10.000 32 チアルブリンE 10,000 50 結果は寒天希釈法で得た。ディスクの直径−6mm、−°=アイスクの直径以上 のゾーンなし 表7 異なる方法によるLC6゜(24時間)データ24時間中にカンジダ・アルビカ ンスの50%増殖阻止に必要な用カンジダ・アルビカンス 4076 6456 P815肥満細胞腫 81 85 28 50.000チアルブリンD (Th D)の分解に間するデータは、24時間の暴露でカンジダ・アルビカンスの50 %増殖阻止(LC,。24時間)に必要な濃度の変化として表した。Table 6 Against thialbulin A, D, E, Aspergillus fumigalas Chialburin A 10,000. 27 Chialbrin D 10.000 32 Chealburin E 10,000 50 The results were obtained by the agar dilution method. Disk diameter -6mm, -° = greater than the diameter of the ice disk no zone of Table 7 LC6° (24 hours) data by different methods Candida albica during 24 hours Candida albicans 4076 6456 required to inhibit the growth of Candida albicans by 50% P815 Mast cell tumor 81 85 28 50.000 Thialbulin D (Th D) The data regarding the degradation of Candida albicans after 24 hours of exposure Expressed as the change in concentration required for % growth inhibition (LC, 24 hours).
表8A “ペンヂクール・ホワイト・ライト(“Bench″Coo124時間 ”5, 000 6時間 ’ 5.000 0.5時間 140 0分 7 表8B 水溶液(サブロー・デキストロース培地)中のThDの温度および時間依存分解 24時間 210 110 6時間 8542 2時間 3322 0.5時間 2016 0時間 77 表9 種々のpH(5,6,7,8)のリン酸ナトリウム緩衝液にThDを2時間さら した時の影響表10 サブロー・デキストロース培地(SAB)へのSAB + 5%FBS 14 SAB + 10% FBS 、 16表12 種々の細胞数のカンジダ・アルビカンスを阻10’/m1 16 1.0”/ml 42 表13 3種のチアルブリンF、G、H1および化合物Xが単離され、その有効性が見い 出された カンジダ・アルビカンス 6 8 4 ’5.000P815肥満細胞腫 1. 40 90 59 −植物中の濃度 HL−HHLLL 分解物質 TTTTTTTT 安定性 LLLHHHHH 抗−カンジダ YYYYYYYY 抗−アスペルギルス YYYYYYY?抗−細菌 YYYYYYY? 記号の説明 H=高:L=低;T=チオフェン、Y=育;y=低活性;?=試験せず 当分野で習熟した者にはあきらかであるように、前述の開示にかんがみて、本発 明の実施にあたり本発明の精神と範囲を逸脱することなく、多くの変更並びに修 飾が可能である。Table 8A “Pendicool White Light (“Bench”Coo124 Hours”5, 000 6 hours’ 5.000 0.5 hours 140 0 minutes 7 Table 8B Temperature- and time-dependent degradation of ThD in aqueous solution (Sabouraud-dextrose medium) 24 hours 210 110 6 hours 8542 2 hours 3322 0.5 hours 2016 0 hours 77 Table 9 ThD was exposed to sodium phosphate buffers of various pH (5, 6, 7, 8) for 2 hours. Effect table 10 when Sabouraud dextrose medium (SAB) to SAB + 5% FBS 14 SAB + 10% FBS, 16 Table 12 Inhibits Candida albicans with various cell numbers 10'/m1 16 1.0”/ml 42 Table 13 Three types of thialbulin F, G, H1 and compound X were isolated and their efficacy was determined. served Candida albicans 6 8 4’5.000P815 Mast cell tumor 1. 40 90 59 - Concentration in plants HL - HHLLL Decomposition material TTTTTTTT Stability LLLHHHHHH Anti-Candida YYYYYYYY Anti-Aspergillus YYYYYYY? Anti-bacterial YYYYYYY? Explanation of symbols H=high: L=low; T=thiophene, Y=growth; y=low activity;? = Not tested As will be apparent to those skilled in the art, in view of the foregoing disclosures, Many changes and modifications may be made in carrying out the invention without departing from the spirit and scope of the invention. It can be decorated.
夏杓 本発明は抗真菌剤および抗生物質として宵月な、新規チアルブリン物質並びに密 接に関連した誘導体に関する。summer scoop The present invention provides a novel thialubulin substance and a highly effective antifungal agent and antibiotic. related to derivatives.
国際調査報告 国際調査報告 C^9000435 SA 42426international search report international search report C^9000435 SA 42426
Claims (28)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US44789389A | 1989-12-07 | 1989-12-07 | |
US447,893 | 1989-12-07 | ||
US07/568,940 US5202348A (en) | 1989-12-07 | 1990-08-17 | Thiarubrine antifungal agents |
US568,940 | 1990-08-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH05502220A true JPH05502220A (en) | 1993-04-22 |
Family
ID=27035141
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP3500613A Withdrawn JPH05502220A (en) | 1989-12-07 | 1990-12-07 | Thialbulin antifungal and antibiotic |
Country Status (5)
Country | Link |
---|---|
US (1) | US5202348A (en) |
EP (1) | EP0504186A1 (en) |
JP (1) | JPH05502220A (en) |
CA (1) | CA2070650A1 (en) |
WO (1) | WO1991009027A1 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5556875A (en) * | 1993-08-24 | 1996-09-17 | Shaman Pharmaceuticals, Inc. | 1,2-dithiin antiinfective agents |
AU1989195A (en) * | 1994-03-11 | 1995-09-25 | Shaman Pharmaceuticals, Inc. | Preparation of symmetrical and unsymmetrical dithiin compounds |
US5583235A (en) * | 1994-03-11 | 1996-12-10 | Shaman Pharmaceuticals, Inc. | Preparation of symmetrical and unsymmetrical 3,6-disubstituted-1,2-dithiins having antifungal activity |
US5648354A (en) * | 1994-03-11 | 1997-07-15 | Shaman Pharmaceuticals, Inc. | 1,2-dithiins having antifungal activity |
US5580897A (en) * | 1994-03-11 | 1996-12-03 | Shaman Pharmaceuticals, Inc. | 1,2-dithiins having antifungal activity |
US5453500A (en) * | 1994-05-26 | 1995-09-26 | The University Of Michigan | Water-soluble glycosylated derivatives of 1,2-dithiin compounds |
US5478959A (en) * | 1994-10-05 | 1995-12-26 | The Research Foundation Of State University Of New York | Method for preparing 1,2-dithiins and precursors of 1,2-dithiins |
WO2013140531A1 (en) * | 2012-03-19 | 2013-09-26 | 富士通株式会社 | Cooling device for heat generating devices |
KR20150119755A (en) * | 2014-04-16 | 2015-10-26 | 삼성전자주식회사 | Antibiotic cover and electronic device having therefof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS506758U (en) * | 1973-05-18 | 1975-01-23 | ||
JPS5093078A (en) * | 1973-12-17 | 1975-07-24 | ||
JPS62110245A (en) * | 1985-11-07 | 1987-05-21 | Univ Osaka | Secondary electron spectroscope with strong electric field for extracting secondary electron |
JPS62184752A (en) * | 1986-02-07 | 1987-08-13 | Jeol Ltd | Charged particle beam length meter |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1172460A (en) * | 1981-11-27 | 1984-08-14 | George H.N. Towers | Method for controlling weeds using a naturally occurring conjugated polyacetylene |
CA1169767A (en) * | 1981-11-27 | 1984-06-26 | George H.N. Towers | Cercaricidal compositions containing a naturally occurring conjugated polyacetylene and method for controlling cercariae using the same |
-
1990
- 1990-08-17 US US07/568,940 patent/US5202348A/en not_active Expired - Fee Related
- 1990-12-07 WO PCT/CA1990/000435 patent/WO1991009027A1/en not_active Application Discontinuation
- 1990-12-07 JP JP3500613A patent/JPH05502220A/en not_active Withdrawn
- 1990-12-07 CA CA002070650A patent/CA2070650A1/en not_active Abandoned
- 1990-12-07 EP EP19910900004 patent/EP0504186A1/en not_active Withdrawn
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS506758U (en) * | 1973-05-18 | 1975-01-23 | ||
JPS5093078A (en) * | 1973-12-17 | 1975-07-24 | ||
JPS62110245A (en) * | 1985-11-07 | 1987-05-21 | Univ Osaka | Secondary electron spectroscope with strong electric field for extracting secondary electron |
JPS62184752A (en) * | 1986-02-07 | 1987-08-13 | Jeol Ltd | Charged particle beam length meter |
Also Published As
Publication number | Publication date |
---|---|
US5202348A (en) | 1993-04-13 |
WO1991009027A1 (en) | 1991-06-27 |
CA2070650A1 (en) | 1991-06-08 |
EP0504186A1 (en) | 1992-09-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Nikkon | In vitro Antimicrobial Activity of the Compound Isolated from Chloroform Extract of Moringa oleifera Lam. Farjana Nikkon, Zahangir Alam Saud, M. Habibur Rahman and" Md. Ekramul Haque Department of Biochemistry and Molecular Biology," Department of Pharmacy | |
Abeysinghe | Antibacterial activity of some medicinal mangroves against antibiotic resistant pathogenic bacteria | |
Lee et al. | Antifungal activities of dieckol isolated from the marine brown alga Ecklonia cava against Trichophyton rubrum | |
Bakana et al. | Structure and chemotherapeutical activity of a polyisoprenylated benzophenone from the stem bark of Garcinia huillensis | |
Nithya et al. | Secondary metabolite from Phomopsis sp. isolated from Plumeria acutifolia Poiret | |
Trinh et al. | DPPH-scavenging and antimicrobial activities of Asteraceae medicinal plants on uropathogenic bacteria | |
Ashafa et al. | Screening the root extracts from Biden pilosa L. var. radiata (Asteraceae) for antimicrobial potentials | |
Guo et al. | Triphenyl-sesquineolignan analogues derived from Illicium simonsii Maxim exhibit potent antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA) by disrupting bacterial membranes | |
KR19980702014A (en) | Antimicrobial terpene compound and preparation method thereof | |
Osei Akoto et al. | Anthelminthic, anti-inflammatory, antioxidant, and antimicrobial activities and FTIR analyses of Vernonia camporum stem-bark | |
JPH05502220A (en) | Thialbulin antifungal and antibiotic | |
Al Rashdi et al. | Antioxidant and antibacterial activities of leaves crude extracts of Adenium obesum grown in Oman National Botanical Garden | |
Hölzl et al. | Chemical constituents of Hypericum ssp | |
Chokki et al. | Phytochemical screening and antimicrobial activity of Momordica charantia L. and Morinda lucida Benth extracts from Benin | |
Reid et al. | Isolation of the anti-bacterial vernodalin from traditionally used Vernonia colorata | |
Cheah et al. | Antimicrobial activity of Calophyllum inophyllum crude extracts obtained by pressurized liquid extraction | |
WO2020188534A1 (en) | Phytocomplex and selected extract of a meristematic cell line of a plant belonging to the genus melissa | |
JPH09110712A (en) | Camellia sinensis l. saponin antifungal agent | |
Firmino et al. | Antimicrobial Activity of 3, 4-seco-Diterpenes Isolated from Croton blanchetianus against Streptococcus mutans and Streptococcus parasanguinis | |
Tharmaraj et al. | Screening of bactericidal activity of selected Plumbago species against bacterial pathogens | |
Hassan et al. | Comparative Antimicrobial Activity of Securidaca longipedunculata (Fresen) Extracts on Selected Human Pathogens | |
KR101599911B1 (en) | Compound with antimicrobial activity against grapevine crown gall pathogen isolated from hairy vetch and uses thereof | |
Akoto et al. | Research Article Anthelminthic, Anti-Inflammatory, Antioxidant, and Antimicrobial Activities and FTIR Analyses of Vernonia camporum Stem-Bark | |
BRPI0902598B1 (en) | method for inducing a plant defense mechanism against pathogens, use of a compound and use of the compound 1-o-gallon-2,3; 4,6-bis-hhdp-a / ß-d-glycopyranose | |
EP4311550A1 (en) | Chlorophyllide derivatives for use in the prevention or treatment of bacterial infection |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
LAPS | Cancellation because of no payment of annual fees |